🔬 Cancer Research - Small Cell Lung Cancer and Brain Communication
This article discusses research exploring the potential for small cell lung cancer (SCLC) cells to utilize the brain's communication system to promote their growth.
Key Points:
• Research suggests a functional synapse between neurons and SCLC cells.
• SCLC accounts for a significant portion of lung cancer cases, with a high initial mortality rate.
• The study indicates a potential mechanism by which SCLC fuels its growth.
🔗 Resources:
• AIPulserx ↗ - Life science research
• Nature ↗ - Scientific journal
• University of Cologne ↗ - Research institution
Image
🚀 Pharmaceutical Research - Hit Rate Improvement in Early-Stage R&D
This article describes the potential benefits of improved hit rates in pharmaceutical research and development.
Key Points:
• Higher hit rates lead to fewer wasted assays.
• Improved hit rates accelerate lead optimization processes.
• Significant cost reductions are possible in early-stage R&D.
✨ Healthcare - Healthy Ageing and Vaccines
This article discusses the role of vaccines in promoting healthy aging, focusing on data presented at the ESCMID Vaccines 2025 congress.
Key Points:
• Healthy aging involves both longevity and quality of life.
• Vaccines can contribute to both individual and societal well-being.
• Expert insights highlight the importance of vaccines in healthy aging.
Image
🔗 Resources:
• GSK ↗ - Vaccine developer
• ESCMID Vaccines 2025 ↗ - Vaccine congress
🤖 Healthcare Technology - Musculoskeletal Conditions and Digital Platforms
This article discusses the use of a digital platform to address musculoskeletal (MSK) conditions, particularly within frontline police forces.
Key Points:
• 7.8 million workdays were lost in the UK due to MSK conditions.
• Frontline police officers are disproportionately affected by MSK issues.
• A digital platform provides rapid assessments and recovery plans.
Image
🔗 Resources:
• EQL_AI ↗ - Provider of digital MSK assessment platform
💡 Medical Technology - Abstract Acceptance at EUSOBI 2025
This article announces the acceptance of an abstract for presentation at the EUSOBI 2025 congress.
Key Points:
• An abstract authored by Ana San Roman Gaitero has been accepted.
• The poster will be displayed in the exhibition hall and the official app.
• The presentation will be at the EUSOBI 2025 congress.
Image
🔗 Resources:
• ScreenPoint Medical ↗ - Medical technology company
• EUSOBI 2025 ↗ - Medical technology congress
🤖 Pharmaceutical Research - RNA Drug Discovery
This article discusses the challenges and advancements in RNA drug discovery, focusing on a platform designed to address the complexity of RNA structure.
Key Points:
• RNA's structural flexibility presents significant challenges in drug development.
• A platform is designed to overcome these complexities.
• The platform aims to redefine RNA drug discovery.
🔗 Resources:
• Atomic AI ↗ - RNA drug discovery platform
• Drug Discovery ↗ - Research area
🚀 Software - AI-Native Software for Spectrum Awareness
This article highlights the use of AI-native software for accelerating spectrum awareness, particularly within the open-source and Software Defined Radio (SDR) communities.
Key Points:
• AI-native software accelerates spectrum awareness.
• The software enables faster and smarter signal detection.
• The software will be showcased at GRCon25.
Image
🔗 Resources:
• DeepSig ↗ - Developer of AI-native software
• GRCon25 ↗ - Open-source and SDR community conference
• Software Defined Radio ↗ - Technology area
🤖 Biotechnology - Antibody Developability and Property Prediction
This article provides an overview of resources and best practices for antibody developability and property prediction.
Key Points:
• Guide to antibody developability and property prediction.
• Compilation of best practices and effective in silico tools.
• Focus on key risks in antibody development, such as aggregation propensity.
Image
🔗 Resources:
• Tamarind Bio ↗ - Biotechnology company
💡 Oncology - Pharma CI Conference 2025
This article announces the presence of the Larvol team at the Pharma CI Conference - USA 2025.
Key Points:
• Larvol team will be present at the conference in Newark, NJ.
• Opportunities to connect with Bruno Larvol and Daniel J.
• Focus on oncology conferences, trials, and oncologist feedback.
Image
🔗 Resources:
• Larvol ↗ - Biotechnology company
• Bruno Larvol ↗ - CEO of Larvol
• Daniel J. ↗ - Sr. Product Innovation Manager at Larvol
⭐️ Support
If you liked reading this report, please star ⭐️ this repository and follow me on Github ↗, 𝕏 (previously known as Twitter) ↗ to help others discover these resources and regular updates.
